Journals
View articles of the highest standard and extending to all aspects of human health
Specialties
View collections of articles, reviews, seminars and comments from across our journals
Clinic
View selected content around 136 diseases according to clinical practice needs
Global Health
View selected content to advance health in all regions of the world
Oncology nursing
The Lancet Oncology
Published: November 16, 2020
2020 was designated by WHO as the Year of the Nurse and the Midwife. Oncology nurses are crucial for the cancer care continuum and to achieving the Sustainable Development Goals 3.4 (reduce non-communicable disease morbidity by a third by 2030) and 3.8 (universal health coverage).
In this Series, Annie Young and colleagues provide an overview on the role of oncology nurses throughout the cancer care continuum, from screening to end-of-life care, including their role in research and clinical trials. Julia Challinor and colleagues describe the challenges of this workforce (eg, recruitment, retention, and burnout) and provide several suggestions advocating to include oncology nurses in the decision-making process to achieve cancer control.
IBD in Resource-limited Settings in Asia
The Lancet Gastroenterology & Hepatology
Published: November 9, 2020
The prevalence of inflammatory bowel disease (IBD) is increasing worldwide. In Asia, urbanisation and industrialisation, and accompanying lifestyle changes, have led to increasing prevalence of IBD in the region, with the burden of disease projected to overtake that of high-income countries in the near future. Resource-limited settings pose unique challenges to the diagnosis and management of IBD, particularly in Asia, where there is a high prevalence of infectious diseases that can mimic IBD, high risk of opportunistic infections, few data to formulate regional treatment guidelines, and inadequate public health-care funding. The first paper of the Series outlines the challenges to diagnosis and management of IBD in resource-limited settings, including how screening and management strategies could be modified to minimise disease burden. The second paper of the Series focuses on the optimisation of therapy, including the use of immunomodulators, biologics, and alternative drugs in the management of IBD.
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
The Lancet
Published: November 13, 2020
Over 460 million people worldwide have diabetes, with around 80% of them living in low-income and middle-income countries. Despite high-level commitments to accelerate global action against non-communicable diseases (NCDs), the world is not on-track to reach Sustainable Development Goal 3.4 to reduce premature mortality from major NCDs by 30% between 2015 and 2030. Ahead of World Diabetes Day, this Lancet Commission on diabetes provides a blueprint for closing gaps in diabetes prevention, care, professional knowledge, and data that could save millions of lives. Modelling done by the Commission shows that use of a data-driven, multicomponent, integrated strategy could avert up to 800 000 premature deaths in the top 10 LMICs with the highest populations of people with diabetes. Implementing this Commission’s recommendations will require a whole-of-society approach to transform ecosystems and care environments.
Delivering transformative action in paediatric pain
The Lancet Child & Adolescent Health
Published: October 14, 2020
Every infant, child, and adolescent will experience pain at times throughout their life. Paediatric pain ranges from acute to chronic, and includes procedural, disease-related, breakthrough, and other types of pain. Despite its ubiquity, pain is often silenced and appropriate relief too infrequently given. Undertreated, unrecognised, or poorly managed pain in young people can have long-lasting negative consequences in later life, including continued chronic pain, disability, and distress. It is time for change. This Lancet Child & Adolescent Health Commission presents four transformative goals—to make pain matter, understood, visible, and better. It sets out priorities for clinicians, researchers, funders, and policy makers, and calls for cross-sector collaboration to deliver the action needed to improve the lives of children and adolescents with pain.